Celltrion aims for $3.58 billion in annual sales next year
Korean drugmaker Celltrion plans to achieve annual sales of 5 trillion won ($3.58 billion) next year, driven by the growth of its biosimilar products and a new treatment for autoimmune diseases, its chairman said Wednesday.